WLCC 2019 Volume 1 - A Preview of This Year’s Topics

Friday, January 25, 2019

  • Welcome and Keynote Address


Saturday, January 26, 2019

  • EGFR and ALK in the first-, second-, and third-line
  • Overcoming mechanisms of resistance for targeted therapy
  • New oncogenic drivers including ROS1 and BRAF
  • Future targets, such as RET, MET, and HER2
  • Practical applications of immunotherapy
  • I/O as a single-agent or in combination
  • Differences in approaching squamous and nonsquamous NSCLC
  • Fighting immunotherapy resistance pathways
  • Current topics in lung cancer surgery
  • Best practices for radiation therapy in lung cancer
  • I/O and targeted therapies in the neoadjuvant setting


Sunday, January 27, 2019

  • Methods to integrate palliative care
  • The future of lung cancer therapy
  • Immunotherapy beyond PD-(L)1 and CTLA-4
  • What are the new standards for small cell lung cancer?
  • Emerging approaches for mesothelioma
  • Role of I/O for unresectable disease
  • Managing immune-related adverse events
  • Determining biomarkers for checkpoint inhibitors: PD-L1 vs. TMB
  • What are the new standards of care?

Calendar of Events
Filter By